297 related articles for article (PubMed ID: 26021610)
1. The GHSG Approach to Treating Hodgkin's Lymphoma.
Bröckelmann PJ; Engert A
Curr Hematol Malig Rep; 2015 Sep; 10(3):256-65. PubMed ID: 26021610
[TBL] [Abstract][Full Text] [Related]
2. Salvage therapy in Hodgkin's lymphoma.
Mendler JH; Friedberg JW
Oncologist; 2009 Apr; 14(4):425-32. PubMed ID: 19342476
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Majhail NS; Weisdorf DJ; Defor TE; Miller JS; McGlave PB; Slungaard A; Arora M; Ramsay NK; Orchard PJ; MacMillan ML; Burns LJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1065-72. PubMed ID: 17084370
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
5. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.
Josting A; Franklin J; May M; Koch P; Beykirch MK; Heinz J; Rudolph C; Diehl V; Engert A
J Clin Oncol; 2002 Jan; 20(1):221-30. PubMed ID: 11773173
[TBL] [Abstract][Full Text] [Related]
6. Autologous stem cell transplantation with selected CD34+ cells and unmanipulated peripheral blood stem cells in patients with relapsed and refractory Hodgkin's lymphoma: a single centre experience.
Ballova V; Ladicka M; Vranovsky A; Lakota J
Neoplasma; 2008; 55(5):428-36. PubMed ID: 18665754
[TBL] [Abstract][Full Text] [Related]
7. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
[TBL] [Abstract][Full Text] [Related]
8. High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma.
Aurer I; Nemet D; Mitrović Z; Dujmović D; Bašić-Kinda S; Radman I; Sertić D; Šantek F; Kralik M; Dotlić S; Mazić S; Labar B
Ann Hematol; 2016 Jun; 95(7):1129-36. PubMed ID: 27103009
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin's Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group.
Kesik V; Ataş E; Karakükcü M; Aksoylar S; Erbey F; Taçyıldız N; Küpesiz A; Öniz H; Ünal E; Kansoy S; Öztürk G; Elli M; Kaya Z; Ünal E; Hazar V; Yılmaz Bengoa Ş; Karasu G; Atay D; Dağdemir A; Ören H; Koçak Ü; Yeşilipek MA
Turk J Haematol; 2016 Dec; 33(4):265-272. PubMed ID: 27094103
[TBL] [Abstract][Full Text] [Related]
10. LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre.
Perz JB; Giles C; Szydlo R; O'Shea D; Sanz J; Chaidos A; Wagner S; Davis J; Loaiza S; Marin D; Apperley J; Olavarria E; Rahemtulla A; Lampert I; Naresh K; Samson D; MacDonald D; Kanfer EJ
Bone Marrow Transplant; 2007 Jan; 39(1):41-7. PubMed ID: 17115062
[TBL] [Abstract][Full Text] [Related]
11. SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.
Rueda Domínguez A; Alfaro Lizaso J; de la Cruz Merino L; Gumá I Padró J; Quero Blanco C; Gómez Codina J; Llanos Muñoz M; Martinez Banaclocha N; Rodriguez Abreu D; Provencio Pulla M
Clin Transl Oncol; 2015 Dec; 17(12):1005-13. PubMed ID: 26497354
[TBL] [Abstract][Full Text] [Related]
12. An update on the management of relapsed and primary refractory Hodgkin's disease.
Moskowitz C
Semin Oncol; 2004 Apr; 31(2 Suppl 4):54-9. PubMed ID: 15124135
[TBL] [Abstract][Full Text] [Related]
13. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases].
Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY
Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021
[TBL] [Abstract][Full Text] [Related]
14. [Reaserch Advance on Treatment Strategies for Relapsed/Refractory Hodgkin's Lymphoma--Review].
Jin DC; Zhao L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):343-349. PubMed ID: 32027301
[TBL] [Abstract][Full Text] [Related]
15. Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
Mundt AJ; Sibley G; Williams S; Hallahan D; Nautiyal J; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):261-70. PubMed ID: 7673013
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of 20 cases of refractory Hodgkin's lymphoma.
Yang HL; Zhang YZ; Jiang YZ; Wang XF; Cao Z
Neoplasma; 2017; 64(6):933-937. PubMed ID: 28895420
[TBL] [Abstract][Full Text] [Related]
17. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed or refractory Hodgkin lymphoma: a systematic review with meta-analysis.
Rancea M; von Tresckow B; Monsef I; Engert A; Skoetz N
Crit Rev Oncol Hematol; 2014 Oct; 92(1):1-10. PubMed ID: 24855908
[TBL] [Abstract][Full Text] [Related]
19. Current strategies and new approaches in the treatment of Hodgkin's lymphoma.
Fuchs M; Diehl V; Re D
Pathobiology; 2006; 73(3):126-40. PubMed ID: 17085957
[TBL] [Abstract][Full Text] [Related]
20. Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Eroglu C; Kaynar L; Orhan O; Keklik M; Sahin C; Yildiz OG; Mentes S; Kurnaz F; Aslan D; Sivgin S; Soyuer S; Eser B; Cetin M; Unal A
Am J Clin Oncol; 2015 Feb; 38(1):68-73. PubMed ID: 23563207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
